Cargando…
496. Secondary Prophylaxis for Clostridium difficile Infection: A Physician Practice Assessment
BACKGROUND: Recurrent Clostridium difficile infection (CDI) is associated with significant morbidity, mortality and healthcare related costs. Up to 30% of CDI cases recur, resulting in 83,000 cases of recurrent CDI per year. Although agents for primary and secondary prophylaxis for CDI including the...
Autores principales: | Sampson, Mindy, Zeitler, Kristen, Marcelin, Jasmine R, Aslam, Sadaf, Sinnott, John, Lakshmi, Seetha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253572/ http://dx.doi.org/10.1093/ofid/ofy210.505 |
Ejemplares similares
-
Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
por: Kristen, Zeitler, et al.
Publicado: (2023) -
Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection
por: Zhang, Kevin, et al.
Publicado: (2019) -
2419. Timing of Secondary Prophylaxis Against Clostridium difficile Infection After Antibiotic Exposure
por: Szela, Joel, et al.
Publicado: (2019) -
1033. Thinking Outside the Bowel: Clostridium difficile Bacteremia Case Series
por: Pettigrew, Adam, et al.
Publicado: (2018) -
2415. Oral Vancomycin for Secondary Prophylaxis of Clostridium difficile Infections among High-risk Patients
por: Lew, Alison, et al.
Publicado: (2019)